ES2059408T3 - Un proceso para la preparacion de un compuesto. - Google Patents
Un proceso para la preparacion de un compuesto.Info
- Publication number
- ES2059408T3 ES2059408T3 ES88101386T ES88101386T ES2059408T3 ES 2059408 T3 ES2059408 T3 ES 2059408T3 ES 88101386 T ES88101386 T ES 88101386T ES 88101386 T ES88101386 T ES 88101386T ES 2059408 T3 ES2059408 T3 ES 2059408T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- preparation
- lipoxigenase
- inhibiting
- presented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
- C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D333/58—Radicals substituted by nitrogen atoms
Abstract
COMPUESTOS DE FORMULA (I) DONDE R, R1, R2, R3, X, A, Y, Z, M TIENEN EL SIGNIFICADO QUE SE INDICA EN LA DESCRIPCION. TAMBIEN SE PRESENTAN COMPOSICIONES INHIBIDORES DE LIPOXIGENASA Y UN METODO PARA INHIBIR LA ACTIVIDAD DE LIPOXIGENASA.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1297087A | 1987-02-10 | 1987-02-10 | |
US6078487A | 1987-06-10 | 1987-06-10 | |
US07/138,073 US4873259A (en) | 1987-06-10 | 1988-01-11 | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2059408T3 true ES2059408T3 (es) | 1994-11-16 |
Family
ID=27359744
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES88101386T Expired - Lifetime ES2059408T3 (es) | 1987-02-10 | 1988-02-01 | Un proceso para la preparacion de un compuesto. |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0279263B1 (es) |
JP (1) | JPS63264456A (es) |
KR (1) | KR960004865B1 (es) |
AU (1) | AU608804B2 (es) |
CA (2) | CA1306744C (es) |
DE (1) | DE3882732T2 (es) |
ES (1) | ES2059408T3 (es) |
MX (2) | MX9202874A (es) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1336099C (en) * | 1987-04-24 | 1995-06-27 | James B. Summers, Jr. | Urea based lipoxygenase compounds |
US4822811A (en) * | 1987-11-13 | 1989-04-18 | Abbott Laboratories | Carbazole lipoxygenase inhibiting compounds, compositions and use |
CA1334975C (en) * | 1987-11-13 | 1995-03-28 | James H. Holms | Furan and pyrrole containing lipoxygenase inhibiting compounds |
GB8830427D0 (en) * | 1988-12-30 | 1989-03-01 | Fujisawa Pharmaceutical Co | New hydroxylamine derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same |
US5096919A (en) * | 1989-01-05 | 1992-03-17 | Ciba-Geigy Corporation | Pyrrolylphenyl-substituted hydroxamic acid derivatives |
US5175183A (en) * | 1989-02-01 | 1992-12-29 | Abbott Laboratories | Lipoxygenase inhibiting compounds |
JPH04503074A (ja) * | 1989-02-01 | 1992-06-04 | アボツト・ラボラトリーズ | リポキシゲナーゼ阻止化合物 |
US4960787A (en) * | 1989-02-06 | 1990-10-02 | Ciba-Geigy Corporation | Certain pyrrolyl-substituted hydroxamic acid derivatives |
US5075330A (en) * | 1989-05-26 | 1991-12-24 | Warner-Lambert Co. | N-hydroxyamide, N-hydroxythioamide, N-hydroxyurea, and N-hydroxythiourea derivatives of selected NSAIDS as antiinflammatory agents |
US4981865A (en) * | 1989-05-26 | 1991-01-01 | Warner-Lambert Co. | N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents |
US5112846A (en) * | 1989-05-26 | 1992-05-12 | Warner-Lambert Company | N-hydroxyamide, N-hydroxythioamide, hydroxyurea, and N-hydroxythiourea derivatives of selected nsaids as antiinflammatory agents |
JP3065636B2 (ja) * | 1989-06-29 | 2000-07-17 | 塩野義製薬株式会社 | [ジ―tert―ブチル(ヒドロキシ)フェニルチオ]置換ヒドロキサム酸誘導体 |
US5272145A (en) * | 1989-08-22 | 1993-12-21 | Merck Frosst Canada, Inc. | (Quinolin-2-ylmethoxy)indoles as inhibitors of the biosynthesis of leukotrienes |
IL95584A (en) * | 1989-09-07 | 1995-03-15 | Abbott Lab | Indole-, benzoporene- and benzothiophene compounds including lipoxygenase-inhibiting compounds and pharmaceutical compounds containing them |
US5120752A (en) * | 1989-12-28 | 1992-06-09 | Abbott Laboratories | Cyclopropyl derivative lipoxygenase inhibitors |
US5093356A (en) * | 1990-01-16 | 1992-03-03 | Merck Frosst Canada, Inc. | Indenyl hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase |
GB9002375D0 (en) * | 1990-02-02 | 1990-04-04 | Pfizer Ltd | Triazole antifungal agents |
US5036067A (en) * | 1990-03-14 | 1991-07-30 | Merck & Co., Inc. | Dibenzoheterocyclic hydroxamic acids and hydroxy ureas as inhibitors of 5-lipoxygenase |
KR900016822A (ko) * | 1990-04-20 | 1990-11-14 | 하라 레이노스께 | 슬라이드 프로젝터 |
GB9012252D0 (en) * | 1990-06-01 | 1990-07-18 | Lilly Industries Ltd | Pharmaceutical compounds |
DE69122759T2 (de) * | 1990-07-25 | 1997-05-15 | Abbott Lab | Acetylenderivate mit lipoxygenase inhibitorischer wirkung |
US5476873A (en) * | 1990-07-25 | 1995-12-19 | Abbott Laboratories | Acetylene derivatives having lipoxygenase inhibitory activity |
GB9017351D0 (en) * | 1990-08-08 | 1990-09-19 | Wellcome Found | Medicaments for treatment of atherosclerosis |
JP2528741B2 (ja) * | 1991-01-09 | 1996-08-28 | ファイザー製薬株式会社 | オキサゾ―ル、チアゾ―ルおよびイミダゾ―ル化合物 |
JPH0730061B2 (ja) * | 1991-02-07 | 1995-04-05 | ファイザー製薬株式会社 | ヒドロキサム酸誘導体および組成物 |
US5132319A (en) * | 1991-03-28 | 1992-07-21 | Merck Frosst Canada, Inc. | 1-(hydroxylaminoalkyl) indole derivatives as inhibitors of leukotriene biosynthesis |
US5128364A (en) * | 1991-03-28 | 1992-07-07 | Merck Frosst Canada, Inc. | Pyrrolo[1,2-a]indole hydroxylamine derivatives as inhibitors of leukotriene biosynthesis |
US5283361A (en) * | 1991-04-23 | 1994-02-01 | Eli Lilly And Company | N-hydroxy-N-[3-[2-(halophenylthio)phenyl]prop-2-enyl]ureas as lipoxygenase inhibitors |
US5130485A (en) * | 1991-04-23 | 1992-07-14 | Eli Lilly And Company | N-hydroxy-N-(3-(2-substituted phenyl)prop-2-enyl)ureas and thioureas useful as 5-lipoxygenase inhibiting agents |
US5143927A (en) * | 1991-05-09 | 1992-09-01 | Warner-Lambert Company | 3-(thiazolidone, oxazolidinone, imidazolidinone)-indoles as antiinflammatory agents |
US5250552A (en) * | 1991-05-09 | 1993-10-05 | Warner-Lambert Company | 3-[thiazolidinone, oxazolidinone, imidazolidinone]-indoles as antiinflammatory agents |
US5442111A (en) * | 1991-05-24 | 1995-08-15 | Warner-Lambert Company | 3,5-di-tetriary-4-butyl-4-hydroxyphenyloxy- or tioalkylene N-hydroxyamides, N-hydroxythioamides, N-hydroxyureas, and N-hydroxythioureas as 5-lipoxygenase inhibitors |
JPH0717612B2 (ja) * | 1991-06-28 | 1995-03-01 | ファイザー製薬株式会社 | 新規なテトラヒドロベンズアゼピン誘導体 |
US5214204A (en) * | 1991-07-19 | 1993-05-25 | Abbott Laboratories | Arylamidoalkyl-n-hydroxyurea compounds having lipoxygenase inhibitory activity |
DE4124345A1 (de) * | 1991-07-23 | 1993-01-28 | Gruenenthal Gmbh | Substituierte 3,4-dihydronaphthaline, diese verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel |
EP0526402B1 (en) * | 1991-07-30 | 1998-01-21 | Novartis AG | Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors |
US5334600A (en) * | 1991-07-30 | 1994-08-02 | Ciba-Geigy Corporation | Isoquinolyl substituted hydroxylamine derivatives |
US5350761A (en) * | 1991-07-30 | 1994-09-27 | Ciba-Geigy Corporation | Indolyl substituted hydroxylamine derivatives |
US5260316A (en) * | 1991-07-30 | 1993-11-09 | Ciba-Geigy Corporation | Isoquinolyl substituted hydroxylamine derivatives |
US5124347A (en) * | 1991-07-31 | 1992-06-23 | Warner-Lambert Co. | 3-5-ditertiarybutylphenyl-4-hydroxymethylidene derivatives of 1,3-dihydro-2H-indole-2-ones as antiinflammatory agents |
US5308850A (en) * | 1991-09-30 | 1994-05-03 | Merck Frosst Canada, Inc. | (Bicyclic-hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
US5190968A (en) * | 1991-09-30 | 1993-03-02 | Merck Frosst Canada, Inc. | (Polycyclic-arylmethoxy) indoles as inhibitors of leukotriene biosynthesis |
US5290798A (en) * | 1991-09-30 | 1994-03-01 | Merck Frosst Canada, Inc. | (hetero-arylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
US5389650A (en) * | 1991-09-30 | 1995-02-14 | Merck Frosst Canada, Inc. | (Azaarylmethoxy)indoles as inhibitors of leukotriene biosynthesis |
US5234933A (en) * | 1991-10-31 | 1993-08-10 | Board Of Governors Of Wayne State University And Vanderbilt University | Cyclic hydroxamic acids |
FR2687402B1 (fr) * | 1992-02-14 | 1995-06-30 | Lipha | Nouveaux azaindoles, procedes de preparation et medicaments les contenant. |
US5541218A (en) * | 1992-07-23 | 1996-07-30 | Pfizer Inc. | Indolinyl N-hydroxyurea and N-hydroxamic acid derivatives as lipoxygenase inhibitors |
JP2661841B2 (ja) * | 1992-07-23 | 1997-10-08 | ファイザー製薬株式会社 | インドリン誘導体 |
FR2695930B1 (fr) * | 1992-09-22 | 1994-12-23 | Sanofi Elf | Dérivé du 2-éthyl benzo[b]thiophène, son procédé de préparation et son utilisation comme intermédiaire de synthèse. |
US5374635A (en) * | 1993-03-29 | 1994-12-20 | Merck Frosst Canada, Inc. | Furo[3,2-b]pyridines and thieno[3,2-b]pyridines as inhibitors of leukotriene biosynthesis |
JPH08510253A (ja) * | 1993-05-10 | 1996-10-29 | セプラコール・インコーポレーテッド | 光学的に純粋な(−)‐ジロイトンを用いて、喘息、アテローム性動脈硬化症および炎症性疾患を治療する方法および組成 |
JP3322885B2 (ja) * | 1995-02-02 | 2002-09-09 | 日研化学株式会社 | N−ヒドロキシウレア誘導体 |
DE10103506A1 (de) * | 2001-01-26 | 2002-08-14 | Ingo S Neu | Pharmazeutische Zusammensetzung zur Behandlung von Multiple Sklerose |
WO2003011848A1 (en) * | 2001-07-30 | 2003-02-13 | Millennium Pharmaceuticals, Inc. | Benzoheterocycles as lipoxygenase inhitibors |
JP2004256511A (ja) * | 2003-02-27 | 2004-09-16 | Yasuo Kikukawa | ピコリンボランを用いる還元反応 |
AR050253A1 (es) | 2004-06-24 | 2006-10-11 | Smithkline Beecham Corp | Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento |
PE20060748A1 (es) | 2004-09-21 | 2006-10-01 | Smithkline Beecham Corp | Derivados de indolcarboxamida como inhibidores de quinasa ikk2 |
US8063071B2 (en) | 2007-10-31 | 2011-11-22 | GlaxoSmithKline, LLC | Chemical compounds |
US8003684B2 (en) | 2006-02-21 | 2011-08-23 | Cornerstone Therapeutics, Inc. | Crystal form and pharmaceutical compositions of (+)-R-zileuton |
KR20080103584A (ko) | 2006-03-30 | 2008-11-27 | 아사히 가세이 파마 가부시키가이샤 | 치환 이환식 환상 유도체 및 그 용도 |
PE20081889A1 (es) | 2007-03-23 | 2009-03-05 | Smithkline Beecham Corp | Indol carboxamidas como inhibidores de ikk2 |
KR101269393B1 (ko) | 2008-04-28 | 2013-05-29 | 아사히 가세이 파마 가부시키가이샤 | 페닐프로피온산 유도체 및 이의 용도 |
EP2351743A4 (en) * | 2008-10-27 | 2012-05-09 | Takeda Pharmaceutical | BICYCLIC CONNECTION |
US8354539B2 (en) | 2009-03-10 | 2013-01-15 | Glaxo Group Limited | Indole derivatives as IKK2 inhibitors |
CA2926950C (en) | 2013-10-10 | 2022-10-11 | Eastern Virginia Medical School | 4-((2-hydroxy-3-methoxybenzyl)amino) benzenesulfonamide derivatives as potent and selective inhibitors of 12-lipoxygenase |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1229580A (es) * | 1967-12-15 | 1971-04-28 |
-
1988
- 1988-02-01 DE DE88101386T patent/DE3882732T2/de not_active Expired - Lifetime
- 1988-02-01 EP EP88101386A patent/EP0279263B1/en not_active Expired - Lifetime
- 1988-02-01 ES ES88101386T patent/ES2059408T3/es not_active Expired - Lifetime
- 1988-02-09 KR KR1019880001201A patent/KR960004865B1/ko not_active IP Right Cessation
- 1988-02-09 AU AU11433/88A patent/AU608804B2/en not_active Expired
- 1988-02-09 CA CA000558457A patent/CA1306744C/en not_active Expired - Lifetime
- 1988-02-10 JP JP63031683A patent/JPS63264456A/ja active Granted
-
1991
- 1991-06-18 CA CA000616096A patent/CA1327204C/en not_active Expired - Lifetime
-
1992
- 1992-06-15 MX MX9202874A patent/MX9202874A/es unknown
- 1992-06-24 MX MX9203187A patent/MX9203187A/es unknown
Also Published As
Publication number | Publication date |
---|---|
JPS63264456A (ja) | 1988-11-01 |
DE3882732T2 (de) | 1993-12-02 |
EP0279263B1 (en) | 1993-08-04 |
CA1327204C (en) | 1994-02-22 |
MX9203187A (es) | 1992-07-01 |
DE3882732D1 (de) | 1993-09-09 |
EP0279263A2 (en) | 1988-08-24 |
AU1143388A (en) | 1988-08-11 |
CA1306744C (en) | 1992-08-25 |
EP0279263A3 (en) | 1989-12-27 |
AU608804B2 (en) | 1991-04-18 |
KR890012994A (ko) | 1989-09-20 |
JPH0569822B2 (es) | 1993-10-01 |
MX9202874A (es) | 1992-06-30 |
KR960004865B1 (ko) | 1996-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2059408T3 (es) | Un proceso para la preparacion de un compuesto. | |
SE8502573D0 (sv) | Fluorescent lanthanide chelates useful as labels of physiologically active materials | |
ATE150462T1 (de) | Pyrazolopyridinverbindungen und verfahren zu ihrer herstellung | |
ES2053609T3 (es) | Derivados de urea inhibidores de lipoxigenasa. | |
MY103850A (en) | Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them. | |
JPS5412381A (en) | N-alkylpiperidine derivative | |
PT83961B (pt) | Processo para a preparacao de derivados da pirazolina e de composicoes insecticidas e acaricidas que os contem | |
ATE153022T1 (de) | 3',5'-ditertbutyl-4'-hydroxyflavone, verfahren zu ihrer herstellung und pharmazeutische zusammensetzung mit antioxidations- und antivasokonstriktionsaktivität | |
ATE156829T1 (de) | Substituierte aminophosphonatderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen | |
PT83535B (pt) | Processo para a preparacao de composicoes farmaceuticas contendo derivados de aminoacidos | |
ES2043863T3 (es) | Procedimiento para preparar derivados de la 1,2,5,6-tetrahidropiridina. | |
DK166323C (da) | Griseolsyrederivater og farmaceutiske midler indeholdende disse | |
DE3882438D1 (de) | Alkansulfonanilid-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung. | |
DE3578687D1 (de) | N-substituierte neuraminsaeure-derivate und verfahren zu ihrer herstellung. | |
EP0186023A3 (en) | Biliary acid derivatives, process for their preparation and pharmaceutical compositions containing them | |
DE69710909D1 (de) | Substituierte tetrahydropyridinderivate, verfahren zu ihrer herstellung und diese enthaltende arzneimittel | |
DE58900439D1 (de) | N-substituierte-n-nitroso-aminoacetonitrile, verfahren zu ihrer herstellung und ihre verwendung. | |
DK218388A (da) | Aktivt princip isoleret fra hajvaev | |
MX9702089A (es) | Carboxamidas biciclicas como antagonistas de 5-ht1a. | |
DE3576154D1 (de) | 5-cyanopyridine-2-diazohydroxide, basische salze und verfahren zu ihrer herstellung und anwendung. | |
ES2043778T3 (es) | Procedimiento para preparar oxiindanos y tetrahidronaftalenos herbicidas. | |
PH23127A (en) | 2,3-diamino-2,3-didesoxyhexose derivatives,their pharmaceutical composition and method of using said compound | |
ES2032838T3 (es) | Un procedimiento para preparar derivados tetrahidropirido (1,2-a)indol. | |
DE3579401D1 (de) | Indolo-(6,5,4-cd)-indol derivate und verfahren zu deren herstellung. | |
ES8707939A1 (es) | Procedimiento para preparar derivados de n-carboxialquil-2--oxo-3-diaril-5,6-triazinas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 279263 Country of ref document: ES |